These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4662244)

  • 21. Initial intensive chemotherapy in tuberculosis.
    Prijyanonda B; Subcharoen S; Korkiat K; Chatrapolraks T; Dhumvipat P
    J Med Assoc Thai; 1973 Jul; 56(7):420-5. PubMed ID: 4805906
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pulmonary tuberculosis with cavitation].
    Aoyagi T
    Naika; 1967 Nov; 20(5):908-15. PubMed ID: 5599392
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical use of capromycin in pulmonary tuberculosis].
    Zierski M; Bek E
    Gruzlica; 1969 Jul; 37(7):649-57. PubMed ID: 4900503
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of drug resistant tuberculosis.
    Supcharoen S
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():286-7. PubMed ID: 4468025
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antimycobacterial therapy in processes caused by primarily resistant bacteria].
    De Michele G
    Arch Monaldi; 1972; 27(4):487-94. PubMed ID: 4680310
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE; Svitneva AS; Tarasova EF
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic effect of ofloxacin on 'treatment-failure' pulmonary tuberculosis].
    Tsunekawa H; Miyachi T; Nakamura E; Tsukamura M; Amano H
    Kekkaku; 1987 Sep; 62(9):435-9. PubMed ID: 3480971
    [No Abstract]   [Full Text] [Related]  

  • 28. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 29. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study on the re-treatment of pulmonary tuberculosis with special reference to resistance to primary drugs].
    Kaku R
    Kekkaku; 1968 Dec; 43(12):520-1. PubMed ID: 5716117
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical importance of primary resistance to major drugs in pulmonary tuberculosis patients].
    Balestrino E; Pio A
    Torax; 1967 Jun; 16(2):64-9. PubMed ID: 5614163
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sources of tuberculous infection in the incidence of lung tuberculosis in Middle-Bohemian Region in 1967 (author's transl)].
    Véznerová A; Polánský F
    Cesk Epidemiol Mikrobiol Imunol; 1974 May; 23(3):150-9. PubMed ID: 4280953
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current views on treatment of tuberculosis. Symposium (VI). Current resistance problems in Uppsala patients].
    Hillerdal O
    Lakartidningen; 1966 May; 63(18):1757-8. PubMed ID: 5917520
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monotherapy with ethambutol in chronic drug-resistant tuberculosis].
    Duchi G; Mostardini G; Palatresi R
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):41-58. PubMed ID: 5621900
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary drug-resistance to principal antitubercular agents used in children].
    Bujko K; Zapaśnik-Kobierska MH; Maliszewska Z; Kostrzeński W
    Pediatr Pol; 1965 Aug; 40(8):773-80. PubMed ID: 5294914
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chemotherapy of tuberculosis--its prerequists, possibilities and limitations].
    Heymer A; Schwabe KH
    Internist (Berl); 1966 Oct; 7(10):502-9. PubMed ID: 4967296
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of treatment of pulmonary tuberculosis in aged patients (after 6-years of observation)].
    Smaga M; Cyganiewicz E; Mysakowska H
    Gruzlica; 1967; 35(11):1181-6. PubMed ID: 6063622
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 Jun; 22(6):519-34. PubMed ID: 4973216
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current data on primary resistance in pulmonary tuberculosis in adults in France. 2d survey of the Centre d'Etudes sur la Resistance Primaire: 1965-1966].
    Canetti G; Kreis B; Thibier R; Gay P; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1967 Jun; 31(4):433-74. PubMed ID: 4974609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.